|
COPD“肥胖悖论”的相关混杂因素分析
|
Abstract:
低体重指数(Body Mass Index, BMI)是慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)患者死亡的独立危险因素,COPD的发生发展与体重减轻和骨骼肌萎缩相关。然而,目前肥胖的全球流行改变了COPD患者所观察到的营养异常的性质。近几年国内外众多研究结果提示,COPD患者同冠心病、心力衰竭、高血压、II型糖尿病一样,也存在“肥胖悖论”,即肥胖未必缩短患者的预期生存时间,对一些慢性病而言,可能反而是保护性因素。然而关于“肥胖悖论”的议题一直存在争议。这一议题对慢性阻塞性肺疾病亦非常感兴趣,也是正在进行研究的一个重要领域。但现有证据来看,肥胖与COPD之间的关系似乎更加复杂,其中多个混杂因素参与并导致了这一结果。
Low Body Mass Index (BMI) is an independent risk factor for death in patients with Chronic Ob-structive pulmonary Disease (COPD), the development of which is associated with weight loss and skeletal muscle atrophy. However, the current global epidemic of obesity has changed the nature of the nutritional abnormalities observed in patients with COPD. In recent years, many domestic and foreign research results suggest that COPD patients, like coronary heart disease, heart failure, hypertension, type II diabetes, there is also an “obesity paradox”, that is, obesity may not shorten the expected survival time of patients, but for some chronic diseases, may be a protective factor. However, the issue of the obesity paradox remains controversial. This topic is also of great interest to chronic obstructive pulmonary disease and is an important area of ongoing research. But the available evidence suggests that the relationship between obesity and COPD is more complex, with multiple confounding factors contributing to the outcome.
[1] | [1] Ramachandran, K., McCusker, C., Connors, M., Zuwallack, R. and Lahiri, B. (2008) The Influence of Obesity on Pulmonary Rehabilitation Outcomes in Patients with COPD. Chronic Respiratory Disease, 5, 205-209.
https://doi.org/10.1177/1479972308096711 |
[2] | Galesanu, R.G., Bernard, S., Marquis, K., et al. (2014) Obesity in Chronic Obstructive Pulmonary Disease: Is Fatter Really Better. Canadian Respiratory Journal, 21, 297-301. https://doi.org/10.1155/2014/181074 |
[3] | Goto, T., Hirayama, A., Faridi, M.K., et al. (2018) Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society, 15, 184-191.
https://doi.org/10.1513/AnnalsATS.201706-485OC |
[4] | Khan, S.S., Ning, H., Wilkins, J.T., et al. (2018) Asso-ciation of Body Mass Index with Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Car-diology, 3, 280-287. https://doi.org/10.1001/jamacardio.2018.0022 |
[5] | Wouters, E. (2017) Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society, 14, S389-S394. https://doi.org/10.1513/AnnalsATS.201705-371AW |
[6] | Guo, Y., Zhang, T., Wang, Z., et al. (2016) Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Dose-Response Meta-Analysis. Medicine (Baltimore), 95, e4225. https://doi.org/10.1097/MD.0000000000004225 |
[7] | Steuten, L.M., Creutzberg, E.C., Vrijhoef, H.J. and Wouters, E.F. (2006) COPD as a Multicomponent Disease: Inventory of Dyspnoea, Underweight, Obesity and Fat Free Mass Depletion in Primary Care. Primary Care Respiratory Journal, 15, 84-91. https://doi.org/10.1016/j.pcrj.2005.09.001 |
[8] | Montes de Oca, M., Torres, S.H., Gonzalez, Y., et al. (2006) Pe-ripheral Muscle Composition and Health Status in Patients with COPD. Respiratory Medicine, 100, 1800-1806. https://doi.org/10.1016/j.rmed.2006.01.020 |
[9] | Lainscak, M., von Haehling, S., Doehner, W., et al. (2011) Body Mass Index and Prognosis in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Cachexia, Sarcopenia and Muscle, 2, 81-86. https://doi.org/10.1007/s13539-011-0023-9 |
[10] | Barnes, P.J. and Celli, B.R. (2009) Systemic Manifestations and Comorbidities of COPD. European Respiratory Journal, 33, 1165-1185. https://doi.org/10.1183/09031936.00128008 |
[11] | Guenette, J.A., Jensen, D. and Donnell, D.E. (2010) Respiratory Function and the Obesity Paradox. Current Opinion in Clinical Nutrition & Metabolic Care, 13, 618-624. https://doi.org/10.1097/MCO.0b013e32833e3453 |
[12] | Kurosaki, H., Ishii, T., Motohashi, N., et al. (2009) Extent of Emphysema on HRCT Affects Loss of Fat-Free Mass and Fat Mass in COPD. Internal Medicine, 48, 41-48. https://doi.org/10.2169/internalmedicine.48.1102 |
[13] | Oey, I.F., Bal, S., Spyt, T.J., et al. (2004) The Increase in Body Mass Index Observed after Lung Volume Reduction May Act as Surrogate Marker of Improved Health Status. Respiratory Medicine, 98, 247-253.
https://doi.org/10.1016/j.rmed.2003.09.017 |
[14] | Oelsner, E.C., Carr, J.J., Enright, P.L., et al. (2016) Percent Emphysema Is Associated with Respiratory and Lung Cancer Mortality in the General Population: A Cohort Study. Thorax, 71, 624-632.
https://doi.org/10.1136/thoraxjnl-2015-207822 |
[15] | Snijder, M.B., van Dam, R.M., Visser, M. and Seidell, J.C. (2006) What Aspects of Body Fat Are Particularly Hazardous and How Do We Measure Them. International Journal of Epidemiology, 35, 83-92.
https://doi.org/10.1093/ije/dyi253 |
[16] | McAuley, P.A. and Beavers, K.M. (2014) Contribution of Cardiorespiratory Fitness to the Obesity Paradox. Progress in Cardiovascular Diseases, 56, 434-440. https://doi.org/10.1016/j.pcad.2013.09.006 |
[17] | Canoy, D. (2003) Abdominal Obesity and Cardiovascular Disease Risk in Older British Men and Women: A Population-Based Study. University of Cambridge, Cambridge. |
[18] | Vatrella, A., Calabrese, C., Mattiello, A., et al. (2016) Abdominal Adiposity Is an Early Marker of Pulmonary Function Impairment: Findings from a Mediterranean Italian Female Cohort. Nutrition, Metabolism & Cardiovascular Diseases, 26, 643-648. https://doi.org/10.1016/j.numecd.2015.12.013 |
[19] | Park, B.H., Park, M.S., Chang, J., et al. (2012) Chronic Obstructive Pulmonary Disease and Metabolic Syndrome: A Nationwide Survey in Korea. The International Journal of Tuberculosis and Lung Disease, 16, 694-700.
https://doi.org/10.5588/ijtld.11.0180 |
[20] | Pishgar, F., Shabani, M., Quinaglia, A.C., Silva, T., et al. (2021) Quantitative Analysis of Adipose Depots by Using Chest CT and Associations with All-Cause Mortality in Chronic Obstructive Pulmonary Disease: Longitudinal Analysis from MESArthritis Ancillary Study. Radiology, 299, 703-711. https://doi.org/10.1148/radiol.2021203959 |
[21] | Stokes, A. and Preston, S.H. (2015) Smoking and Reverse Causation Create an Obesity Paradox in Cardiovascular Disease. Obesity (Silver Spring), 23, 2485-2490. https://doi.org/10.1002/oby.21239 |
[22] | Wu, T.D., McCormack, M.C., Wise, R.A. and Brigham, E. (2019) The Obesity Paradox in COPD Is Absent in US Never-Smokers. American Journal of Respiratory and Critical Care Medicine, 199, A4856.
https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A4856 |